These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Human epidermal growth factor (h-EGF) in gastric carcinomas].
    Author: Fushida S, Yonemura Y, Sugiyama K, Matsumoto H, Kamata T, Miwa K, Miyazaki I.
    Journal: Nihon Geka Gakkai Zasshi; 1988 Dec; 89(12):1965-8. PubMed ID: 3265984.
    Abstract:
    Two hundred and twenty one gastric carcinomas were immunohistochemically stained for h-EGF and we examined the correlation between h-EGF immunoreactivities and histologic findings. Regarding macroscopic and histologic types, incidence of h-EGF immunoreactivities in infiltrating type and in poorly differentiated type was significantly higher than those in localized type and in differentiated type, respectively. In addition, h-EGF producing carcinomas showed high positive rate in prognostic serosal involvement and scirrhous type in stroma. Prognosis in patients with h-EGF producing tumors was poorer than that in those with h-EGF non-producing tumors, especially in stages II and III. These results suggest that h-EGF immunoreactivities serves as a biological marker of high malignancy.
    [Abstract] [Full Text] [Related] [New Search]